| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 05/24/2006 | EP1531666A4 Inducible eukaryotic expression system |
| 05/24/2006 | EP1416791B1 An animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy |
| 05/24/2006 | EP0892809B1 Fhit proteins and nucleic acids and methods based thereon |
| 05/24/2006 | EP0874898B1 Protein c production in transgenic animals |
| 05/24/2006 | DE19946173B4 Expression der bovinen Acetyl-Coenzym A Carboxylase α Expression of bovine acetyl-coenzyme A carboxylase α |
| 05/24/2006 | CN2781779Y Novel snakes breeding case |
| 05/24/2006 | CN1777676A Schizophrenia-related voltage-gated ion channel gene and protein |
| 05/24/2006 | CN1775946A Enhanced virus-mediated DNA transfer |
| 05/24/2006 | CN1775013A Method for increasing Gaoyou duck two-yolk egg yield by auto-blood transfusion |
| 05/23/2006 | US7049480 Methods of enucleating an avian oocyte or zygote using two-photon laser scanning microscopy |
| 05/23/2006 | US7049426 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| 05/23/2006 | US7049119 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2006 | US7048921 Neural transplantation using pluripotent neuroepithelial cells |
| 05/23/2006 | CA2547572A1 Cattle beta-casein gene targeting vector using homologous recombination |
| 05/23/2006 | CA2075206C Production of recombinant polypeptides by bovine species and transgenic methods |
| 05/18/2006 | WO2006053130A2 Composition and method for clusterin-mediated stem cell therapy for treatment of atherosclerosis and heart failure |
| 05/18/2006 | WO2006052994A2 Systems and methods for improving efficiencies in avian species |
| 05/18/2006 | WO2006051172A1 Method for testing a compound for a therapeutic effect and a diagnostic method |
| 05/18/2006 | WO2006019954A3 In vivo assays for modulation of smad-mediated signaling |
| 05/18/2006 | WO2005123962A3 Gene targeting in eukaryotic cells by group II intron ribonucleoprotein particles |
| 05/18/2006 | WO2005117577A3 Model for neurodegenerative disorders |
| 05/18/2006 | WO2005058028A3 Novel gene disruptions, compositions and methods relating thereto |
| 05/18/2006 | WO2004074445A3 Model for studying the role of genes in tumor resistance to chemotherapy |
| 05/18/2006 | WO2004006837A3 Mesothelin vaccines and model systems |
| 05/18/2006 | US20060107341 An isolated nucleotide sequence encoding a regulatory fusion protein consisting of modified ligand-binding domain of a human estrogen receptor and a transcription blocking domain comprising a mutated restriction enzyme capable of binding but not cleaving DNA |
| 05/18/2006 | US20060107340 Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto |
| 05/18/2006 | US20060107339 Transgenic cell comprising human leukocyte antigen binding peptide for use as tools diagnosis, prevention and treatment of cell proliferative disorders; genetic vaccines |
| 05/18/2006 | US20060107338 Hepatic cirrhosis model animal and method of constructing the same |
| 05/18/2006 | US20060107337 Elimination of endogenous porcine retrovirus |
| 05/18/2006 | US20060107336 Nonbacterial prostatitis model animal |
| 05/18/2006 | US20060105977 Desmoglein 4 is a novel gene involved in hair growth |
| 05/18/2006 | US20060105972 Method to enhance delivery of glutathione and ATP levels in cells |
| 05/18/2006 | US20060105347 Fetoproteins; pharmacokinetics; biocompatability; rheumatoid arthritis; multiple sclerosis; cancer |
| 05/18/2006 | US20060105323 Multi-reporter gene model for toxicological screening |
| 05/18/2006 | US20060104968 soluble neutral active Hyaluronidase Glycoproteins (sHASEGPs); use treating glycosaminoglycan associated pathologies such as tumors or eye disorders; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes |
| 05/18/2006 | US20060104905 Methods of screening agents for activity using teleosts |
| 05/18/2006 | CA2586693A1 Systems and methods for improving efficiencies in avian species |
| 05/18/2006 | CA2488113A1 A non-human animal alzheimer's disease model and uses thereof |
| 05/17/2006 | EP1573313A4 Transgenic mice expressing human cd20 and/or cd16 |
| 05/17/2006 | EP1240518A4 Markers for identification and isolation of pancreatic islet alpha and beta cell progenitors |
| 05/17/2006 | EP1214409B1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 05/17/2006 | CN1774507A Nucleic acid controlling the expression of a useful polypeptide in the posterior silk glands of a lepidoptera and application thereof |
| 05/17/2006 | CN1774503A Glyphosate resistant class i 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) |
| 05/17/2006 | CN1774501A Implement and method for freezing and storing egg |
| 05/17/2006 | CN1772891A Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 05/17/2006 | CN1771801A Fleece increasing technology for cashmere goat |
| 05/17/2006 | CN1256015C Method for changing fresh water aquiculture jewfish to mariculture jewfish |
| 05/16/2006 | US7045678 Genetically engineered rodent animal models for identifying fibroblast growth factor expressing cells and diagnosis and treatment of tumors; antiproliferative agents |
| 05/16/2006 | US7045677 Gene expression in milk of transgenic mammals |
| 05/16/2006 | US7045676 producing recombinant protein by inserting into embryo of nonhuman mammal a DNA construct comprising gene encoding protein, said gene being under transcriptional control of milk protein promoter sequence that does not naturally control transcription of gene, transferring embryo to female mammal |
| 05/16/2006 | US7045675 Protein for use in the diagnosis and detection of Niemann-Pick disease |
| 05/16/2006 | US7045616 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045345 G-coupled receptor showing selective affinity for ATP |
| 05/11/2006 | WO2006049439A1 Method of producing xenogenic cd4 t-cell and animal model producing xenogenic cd4 t-cell |
| 05/11/2006 | WO2006048466A2 Animal models comprising at least one conditional ko and one conditional ki |
| 05/11/2006 | WO2006048465A2 Animal models comprising at least one mutation or one conditional ki and one conditional ko |
| 05/11/2006 | WO2006048464A2 Expressing heterologous genes in a specific manner in certain tissues of transgenic animal models |
| 05/11/2006 | WO2005056758A3 Methods and compositions for genetically detecting improved milk production traits in cattle |
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | US20060101534 Transgenic mice containing beta3GalT2 gene disruptions |
| 05/11/2006 | US20060101533 Transgenic mice containing TMEM3 beta-1,3-N-acetylglucosaminyltransferase gene disruptions |
| 05/11/2006 | US20060101532 Methods for the identification of compounds for the treatment of Alzheimer's disease |
| 05/11/2006 | US20060101531 Animal models of cancer development and metastasis |
| 05/11/2006 | US20060101530 Rors as modifiers of the p21 pathway and methods of use |
| 05/11/2006 | US20060101529 Lymphocyte surface receptor that binds CAML and methods of use thereof |
| 05/11/2006 | US20060101528 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment |
| 05/11/2006 | US20060101527 Methods and compositions for screening for modulators of parkinson's disease |
| 05/11/2006 | US20060100416 Novel substitution mutant receptors and their use in an nuclear receptor-based inducible gene expression system |
| 05/11/2006 | US20060099683 Isolated hOAT polypeptide |
| 05/11/2006 | US20060099658 PCA3, PCA3 genes, and methods of use |
| 05/11/2006 | US20060099585 Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases |
| 05/11/2006 | US20060099194 Composition and method for clusterin-mediated stem cell therapy for treatment of atherosclerosis and heart failure |
| 05/11/2006 | US20060099185 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 05/11/2006 | US20060099142 Cancer associated araf1 protein kinase and its uses |
| 05/11/2006 | CA2586542A1 Transgenic non-human animal models of ischemia-reperfusion injury and uses thereof |
| 05/10/2006 | EP1392859B1 Isolating cells expressing secreted proteins |
| 05/10/2006 | EP0990001B1 Processes for production of immunoglobulin a in milk |
| 05/10/2006 | CN2777970Y Fly maggot, earthworm breeding device |
| 05/10/2006 | CN2777969Y Corn seed maggot breeding device |
| 05/10/2006 | CN1769441A Polyploid breeding method for inducing heterogenous tripoid scallop by physical means |
| 05/10/2006 | CN1769432A Ouiescent cell populations for nuclear transfer |
| 05/10/2006 | CN1769431A Ouiescent cell populations for nuclear transfer |
| 05/10/2006 | CN1768581A Method for breeding pork tenderness and its detection kit |
| 05/10/2006 | CN1255024C Pestand fodder separator for housefly larva cultivation |
| 05/09/2006 | US7041871 transgenic mouse comprising in its genome a human kappa light chain immunoglobulin transgene containing five human light chain V kappa segments, L15, L18, L24, A10 and A27, a plurality of human light chain J kappa segments, and human light chain C kappa segment linked to transcription regulatory sequence |
| 05/09/2006 | US7041870 Transgenic mammal for use in the treatmnent of cardiovascular, infections, cancer and autoimmune disorders |
| 05/09/2006 | US7041869 Genetically engineered rodents comprising expression constructs coding luciferase reporter genes for use as tool in identifying cancer preventatives; antitumor agents |
| 05/09/2006 | US7041796 C3b/C4b Complement Receptor-like molecules and uses thereof |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041437 Genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions. |
| 05/09/2006 | US7041291 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 05/09/2006 | US7041282 Ligands for flt3 receptors |
| 05/09/2006 | US7041276 Administering the agent to a teleost and detecting a response in the teleost indicating angiogenesis activity |
| 05/04/2006 | WO2006047603A2 Ungulates with genetically modified immune systems |
| 05/04/2006 | WO2006047367A2 Suppression of endogenous immunoglubolin expression in non-human transgenic animals |
| 05/04/2006 | WO2006000719A3 COG47 PROTEIN AND S100β GENE POLYMORPHISM |
| 05/04/2006 | US20060095984 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 05/04/2006 | US20060095980 Depletion of endogenous primordial germ cells in avian species |
| 05/04/2006 | US20060095979 Transgenic mice containing CLCN4 chloride ion channel gene disruptions |